Molecular regulation of cellular iron balance

Abstract

Handling a life-supporting yet redox-active metal like iron represents a significant challenge to cells and organisms that must not only tightly balance intra- and extracellular iron concentrations but also chaperone it during its journey from its point of entry to final destinations, to prevent inappropriate generation of damaging reactive oxygen species. Accordingly, regulatory mechanisms have been developed to maintain appropriate cellular and body iron levels. In intracellular compartments, about 95% of iron is protein-bound and the expression of the major proteins of iron metabolism is controlled by an integrated and dynamic system involving multilayered levels of regulation. However, dysregulation of iron homeostasis, which could result from both iron-related and unrelated effectors, may occur and have important pathological consequences in a number of human disorders. In this review, we describe the current understanding of the mechanisms that keep cellular iron balance and outline recent advances that increased our knowledge of the molecular physiology of iron metabolism. © 2017 IUBMB Life, 69(6):389-398, 2017.

Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives

“…However, excess iron can facilitate the formation of the most reactive and toxic forms of oxidants through the Fenton reaction [125]. The regulation of cellular iron homeostasis is due to different proteins: the transferrin receptor (TfR1), responsible for transferrin-bound iron up-take, major players in ferroportin (Fpn), the only cellular iron exporter, and ferritin, the iron store protein [126]. An association between high body iron content and cancer in the general population has been demonstrated [127], as well as positive relation between increased body iron stores and the risk of liver cancer [128] (Table 1).…”

ROS‐Mediated Apoptosis and Anticancer Effect Achieved by Artesunate and Auxiliary Fe(II) Released from Ferriferous Oxide‐Containing Recombinant Apoferritin

“…Additionally, the anticancer efficacy of AS is positively correlated with the amount of Fe(II) in the targeted cells . Although the iron content in cancer cells is higher than that in healthy cells, it is usually much lower than that in red blood cells (RBCs) …”

Diabetic macular oedema: under‐represented in the genetic analysis of diabetic retinopathy

“…; Recalcati et al. ). The haemochromatosis gene ( HFE ) is thought to control circulating serum iron levels by regulating the interaction between the transferrin receptor and transferrin.…”